SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-22-051654
Filing Date
2022-04-28
Accepted
2022-04-28 08:09:56
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 tm2212074-6_424b5.htm 424B5 223250
2 GRAPHIC lg_adaptimmune-4c.jpg GRAPHIC 59488
  Complete submission text file 0001104659-22-051654.txt   306475
Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Filer) CIK: 0001621227 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-264208 | Film No.: 22862342
SIC: 2836 Biological Products, (No Diagnostic Substances)